A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma.

被引：0
|
作者：
Cercek, Andrea
Stadler, Zsofia Kinga
Cohen, Jenna L.
Weiss, Jill A.
Lamendola-Essel, Michelle F.
Krishnan, Asha
Yaeger, Rona
Segal, Neil Howard
Connell, Louise Catherine
El Dika, Imane H.
Kemeny, Nancy E.
Saltz, Leonard B.
Smith, Jesse Joshua
Nash, Garrett Michael
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
Diaz, Luis A.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4123
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
    Eric S. Christenson
    Jeffrey Meyer
    Current Oncology Reports, 2022, 24 : 1373 - 1375
  • [42] Phase II study of nivolumab and relatlimab in advanced mismatch repair deficient (dMMR) cancers resistant to prior PD-(L)1 inhibition
    Bever, Katherine M.
    Wang, Hao
    Durham, Jennifer N.
    Petrie, Susan
    Hoare, Jessica
    Wilt, Cara
    Sharfman, William Howard
    Azad, Nilofer Saba
    Laheru, Daniel A.
    Anders, Robert A.
    Pardoll, Drew M.
    Topalian, Suzanne Louise
    Jaffee, Elizabeth M.
    Le, Dung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] A Mismatch Repair-Deficient Hepatoid Adenocarcinoma of the Lung Responding to Anti-PD-L1 Durvalumab Therapy Despite no PD-L1 Expression
    Basse, Victor
    Schick, Ulrike
    Gueguen, Paul
    Le Marechal, Cedric
    Quintin-Roue, Isabelle
    Descourt, Renaud
    Simon, Helene
    Uguen, Arnaud
    Quere, Gilles
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : E120 - E122
  • [44] Neoadjuvant chemoradiotherapy plus PD-1 blockade for high or very high-risk locally advanced rectal cancer
    Liu, X.
    He, L.
    Tong, W.
    Li, S.
    Wang, Z.
    Gu, M.
    Li, Y.
    Liu, Z.
    Chang, P.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S108 - S108
  • [45] Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study
    Yang, Zhengyang
    Gao, Jiale
    Zheng, Jianyong
    Han, Jiagang
    Li, Ang
    Liu, Gang
    Sun, Yi
    Zhang, Jie
    Chen, Guangyong
    Xu, Rui
    Zhang, Xiao
    Liu, Yishan
    Bai, Zhigang
    Deng, Wei
    He, Wei
    Yao, Hongwei
    Zhang, Zhongtao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [46] Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study
    Zhengyang Yang
    Jiale Gao
    Jianyong Zheng
    Jiagang Han
    Ang Li
    Gang Liu
    Yi Sun
    Jie Zhang
    Guangyong Chen
    Rui Xu
    Xiao Zhang
    Yishan Liu
    Zhigang Bai
    Wei Deng
    Wei He
    Hongwei Yao
    Zhongtao Zhang
    Signal Transduction and Targeted Therapy, 9
  • [47] An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results
    Sebag-Montefiore, D.
    Brown, G.
    Rutten, H.
    Rullier, E.
    Peeters, M.
    Glynne-Jones, R.
    Van Cutsem, E.
    Ricci, S.
    Van de Velde, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 170 - 170
  • [48] Phase I/II Study of Preoperative Concurrent Chemoradiotherapy with S-1 for Locally Advanced, Resectable Rectal Adenocarcinoma
    Sadahiro, Sotaro
    Suzuki, Toshiyuki
    Tanaka, Akira
    Okada, Kazutake
    Kamijo, Akemi
    Murayama, Chieko
    Akiba, Takeshi
    Nakayama, Yuko
    ONCOLOGY, 2011, 81 (5-6) : 306 - 311
  • [49] Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study
    Zhang, Bo
    Song, Yan
    Luo, Suxia
    Yin, Xianli
    Li, Enxiao
    Wang, Hui
    He, Yifu
    Liu, Zhihui
    Fan, Qingxia
    Liang, Xinjun
    Shu, Yongqian
    Liu, Yunpeng
    Xu, Nong
    Zhang, Shu
    Zhuang, Zhixiang
    Zhang, Jingdong
    Kou, Xiaoge
    Wang, Fen
    Zhu, Xiaodong
    Zeng, Shan
    Wang, Ke
    Zhong, Haijun
    Li, Shengmian
    Bai, Yuxian
    Yu, Junyan
    Dou, Yiwei
    Ma, Taiyang
    Liu, Qian
    Huang, Jing
    CELL REPORTS MEDICINE, 2023, 4 (12)
  • [50] Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
    Prithviraj, Gopi Kesaria
    Jiang, Kun
    Zhao, Xiuhua
    Chen, Dung-Tsa
    Morse, Brian
    Shridhar, Ravi
    Hoffe, Sarah E.
    Shibata, David
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345